Editorial overview
Aggregated Overview
The project documents bulk and single-cell RNA-seq workflows, a command-line interface, and a BSD-2 license. Scores reflect documented capabilities and setup requirements; no verified review evidence was found.
This profile combines documented product information and independent evidence where available. It is not a hands-on test unless TechZella explicitly identifies one.
Overview
Kallisto is command-line software for estimating transcript abundance from high-throughput RNA-seq reads. Its pseudoalignment method identifies compatible transcript targets without fully aligning each read.
Researchers can use it for bulk RNA-seq and, alongside bustools, for single-cell preprocessing. Kallisto produces quantification outputs for downstream analysis rather than replacing a full downstream statistical-analysis workflow.
Decision guideKallisto Decision Snapshot
A quick way to understand who this product may suit, where its limits matter, and which facts are most relevant before you compare alternatives.
Best suited toResearchers and bioinformatics teams that need command-line transcript quantification for bulk or single-cell RNA-seq, and can manage reference preparation and local execution.
Look elsewhere ifTeams seeking a hosted visual application, vendor-backed support commitments, or an integrated differential-expression analysis interface may need additional tools, and should evaluate alternatives such as Salmon instead.
PlatformsLinux, macOS, Windows
TechZella assessment6.2/10
Decision contextKallisto — What Sets It Apart?
These are the product-specific differences that may matter when deciding whether the software fits your workflow. They are based on documented evidence rather than a universal ranking.
- Uses pseudoalignment to estimate transcript compatibility without performing full read alignment.
- Its kallisto bus workflow supports single-cell RNA-seq preprocessing and works with bustools.
- The project includes documented long-read workflows in its current documentation.
Editorial assessmentKallisto Pros & Cons
Pros
- No-cost software under a permissive BSD-2 license.
- Supports documented bulk and single-cell RNA-seq workflows.
- Connects with companion tools including bustools and sleuth.
- Includes long-read workflows in its documentation.
Cons
- Requires command-line skills and local workflow configuration.
- Release changes can affect supported options and outputs, so version pinning matters.
- The project pages checked do not document a public API or commercial support plan.
Operational limitsKallisto Gotchas & Operational Limits
These are documented constraints or practical friction points that may matter before you adopt the product.
Kallisto v0.50.0 removed several previously available BAM-output and inspection options; v0.52.0 release notes say genomebam and pseudobam were restored.
Pipelines that depend on these options should pin and test a specific version instead of assuming all releases behave alike.
Evidence source ↗The main download page lists older dated binary releases, while newer releases are listed on GitHub.
Users should check the GitHub release page and associated assets when choosing a current binary.
Evidence source ↗ Plans & pricingKallisto Pricing & Plans
Free
$0
one-time
Open-source command-line software under the BSD 2-Clause license. No paid plans or trial are listed.
Check current pricing →Pricing may change. Verify current plans on the vendor's website.
Cost contextTotal Cost & Hidden Costs
Additional costs or implementation requirements that are documented in the available evidence.
Implementation and setup
Installation and analysis require command-line setup, reference indexing, and workflow configuration. The project publishes installation guidance but no paid onboarding offer.
Evidence source ↗Hosting and compute
Kallisto is distributed as software rather than a hosted service. Users provide the machine or computing environment used to run it; no hosting fee is listed by the project.
Evidence source ↗License, support, and add-ons
The software uses a BSD-2 license. The repository directs users to a community help group; commercial support, paid add-ons, and service fees are not specified in the checked project pages.
Evidence source ↗ Compare optionsKallisto Competitors & Alternatives
Compare similar products directly, then see which alternatives may make more sense when your requirements differ.
At a glance
Open Source SoftwareOnly factors supported by the available research are shown. The comparison is descriptive, not a ranking.
Direct competitors
These products address broadly similar requirements. The descriptions focus on documented reasons a buyer might compare them with Kallisto.
SalmonTranscript-level RNA-seq quantification using selective alignment or alignment-free sketch mode; current documentation directs single-cell users to a separate alevin-fry ecosystem.
CapabilitiesKallisto Features
RNA-seq quantification
- Pseudoalignment-based transcript quantification
- Bulk RNA-seq workflow support
- Long-read pseudoalignment workflows
Single-cell processing
- kallisto bus workflow
- BUS output that can be processed with bustools
- Barcode and UMI processing through companion tools
Workflow and installation
- Command-line interface
- Source installation
- Package-manager and binary installation options
Product detailsKallisto Specifications
| Interface | Command line |
|---|
| License | BSD 2-Clause |
|---|
| Deployment | Local installation |
|---|
| Data types | Bulk, single-cell, and documented long-read RNA-seq workflows |
|---|
| API | No public API documented on the checked project pages |
|---|
| Free trial | Not applicable; software is free and open source |
|---|
Our evidence-based assessmentTechZella Score
A proprietary editorial score based on product capabilities, usability, value, performance, support and user sentiment evidence.
6.2/10Moderate confidence
The project documents bulk and single-cell RNA-seq workflows, a command-line interface, and a BSD-2 license. Scores reflect documented capabilities and setup requirements; no verified review evidence was found.
Methodology v1.0. The assessment weighs feature coverage (25%), ease of use (15%), value for money (20%), performance (15%), support (10%) and user sentiment (15%), using researched product evidence and verified review evidence where available. It is a TechZella editorial assessment, not a direct user-review average.
Editorial transparency
Our Review Methodology
Key claims are linked to the sources used to verify them. This evidence record is separate from third-party user ratings.
TechZella evaluates software using documented product capabilities, pricing information, usability and value considerations, independent user evidence where available, and competitive context. The assessment is an editorial review, not a hands-on test unless one is explicitly identified. Our editorial assessment is based on 3 documented sources.
What TechZella adds- Uses pseudoalignment to estimate transcript compatibility without performing full read alignment.
- Its kallisto bus workflow supports single-cell RNA-seq preprocessing and works with bustools.
- The project includes documented long-read workflows in its current documentation.
Important limitations- Kallisto is a command-line tool, so users must prepare inputs, references, and execution workflows.
- The project repository points users to a community Google Group for help rather than documenting a commercial support service.
- Some release changes affect output and build options; check version-specific notes before reusing an older pipeline.
Evidence-backed claimsKallisto estimates transcript abundance from RNA-seq reads using pseudoalignment.The project repository describes pseudoalignment as identifying read compatibility with targets without performing alignment.
View source ↗Verified 2026-11-11Kallisto can be used for bulk and single-cell RNA-seq workflows.The project repository describes bulk analysis with sleuth and single-cell preprocessing with bustools; the workflow documentation covers both data types.
View source ↗Verified 2026-11-11Kallisto is distributed under the BSD-2 license.The repository and project download page identify the BSD 2-Clause license.
View source ↗Verified 2026-11-11Kallisto does not have a documented public API on the checked project pages.The repository and download documentation describe command-line software and source installation; no public API is described in those pages.
View source ↗Verified 2026-11-11The release history includes long-read support and version-specific changes to commands and outputs.Release notes describe long-read support and document the addition, removal, or restoration of specific features across versions.
View source ↗Verified 2026-11-11 Common questionsKallisto FAQs
Answers begin with the clearest available response, followed by the context that helps you act on it.
Is Kallisto free?
Yes. It is distributed under the BSD 2-Clause license.
Does Kallisto support single-cell RNA-seq?
Yes. It can be used with bustools for single-cell preprocessing.
Does Kallisto have a public API?
No. The checked project documentation describes command-line use and does not document a public API.
Does Kallisto include a free trial?
No. A trial is not applicable because the software is free to download under its stated open-source license.
Does Kallisto fully align RNA-seq reads?
No. Its central method is pseudoalignment, which identifies compatible targets without full alignment.
Community feedback
Reviews
No reviews yet. Be the first to share your experience.
Write a Review
Please log in to submit a review.
DirectoryRecently added Open Source Software